SACUBRIGHT 50 Mg Tablet : STERIS Healthcare PVT LTD…...

May 10, 2024

SACUBRIGHT 50 Mg

Sacubitril (24mg), Valsartan (26mg)

SACUBRIGHT 50 is a combination medication containing Sacubitril (24mg) and Valsartan (26mg) as its active ingredients. This medication is commonly prescribed for the management of heart failure with reduced ejection fraction (HFrEF). In this comprehensive guide, we explore the uses, dosage, price, side effects, composition, and other crucial aspects of SACUBRIGHT 50.

Uses of SACUBRIGHT 50

  1. Heart Failure Management: SACUBRIGHT 50 is indicated for the treatment of chronic heart failure with reduced ejection fraction (HFrEF) in adults to reduce the risk of cardiovascular death and hospitalization for heart failure exacerbation.
  2. Blood Pressure Control: Valsartan, one of the components of SACUBRIGHT 50, is an angiotensin receptor blocker (ARB) used to control high blood pressure (hypertension), which is often seen in heart failure patients.
  3. Neprilysin Inhibition: Sacubitril, the other component, is a neprilysin inhibitor that works by enhancing the levels of beneficial peptides while reducing harmful substances that contribute to heart failure progression.

Dosage of SACUBRIGHT 50

The dosage of SACUBRIGHT 50 is carefully determined by the healthcare provider based on individual patient factors such as age, medical history, current medications, and the severity of heart failure. A typical dosage regimen is as follows:

  • The recommended starting dose is one SACUBRIGHT 50 tablet (containing 24mg Sacubitril and 26mg Valsartan) twice daily.
  • Titration may be necessary based on the patient's response and tolerability, with gradual adjustments as directed by the healthcare provider.

It is crucial to adhere strictly to the prescribed dosage and follow-up visits to monitor treatment effectiveness and potential side effects.

Price of SACUBRIGHT 50

The price of SACUBRIGHT 50 can vary depending on factors such as the brand, dosage strength, and the quantity of tablets in a pack. Generally, it is available at competitive prices, making it accessible to patients requiring long-term management of heart failure and hypertension.

Side Effects of SACUBRIGHT 50

While SACUBRIGHT 50 is generally well-tolerated, some individuals may experience mild to moderate side effects. These side effects may include:

  1. Hypotension: Due to the blood pressure-lowering effects of Valsartan, some patients may experience dizziness, lightheadedness, or orthostatic hypotension (drop in blood pressure upon standing).
  2. Hyperkalemia: Valsartan can cause an increase in potassium levels in the blood, which may lead to symptoms such as muscle weakness, irregular heartbeat, or tingling sensations.
  3. Renal Impairment: SACUBRIGHT 50 may affect kidney function, particularly in patients with pre-existing renal impairment or those taking other medications that impact kidney function.
  4. Angioedema: Rarely, angioedema (swelling of the face, lips, tongue, or throat) may occur, especially in patients with a history of angioedema related to previous ACE inhibitor or ARB use.

It is essential to report any persistent or concerning side effects to the healthcare provider promptly.

Composition of SACUBRIGHT 50

Each SACUBRIGHT 50 tablet contains Sacubitril (24mg) and Valsartan (26mg) as active ingredients. These components work synergistically to improve https://www.sterisonline.com/product/sacubright-50-134202, reduce symptoms of heart failure, and manage hypertension in eligible patients. The tablet formulation may also include excipients and inactive ingredients to aid in its stability and effectiveness.

Precautions and Warnings

  • SACUBRIGHT 50 is contraindicated in patients with a history of angioedema related to previous ACE inhibitor or ARB use.
  • It should not be used during pregnancy as it can cause fetal harm. Women of childbearing age should use effective contraception during SACUBRIGHT 50 treatment.
  • Patients with severe renal impairment, hyperkalemia, or hypotension should use SACUBRIGHT 50 with caution and under medical supervision.
  • Regular monitoring of blood pressure, kidney function, and electrolyte levels is recommended during SACUBRIGHT 50 therapy.

Conclusion

SACUBRIGHT 50, combining Sacubitril and Valsartan, is an effective medication for managing heart failure with reduced ejection fraction and hypertension. When used as prescribed and under medical supervision, it can help improve cardiac function, reduce symptoms, and enhance the quality of life for patients with these conditions. However, it is crucial to be aware of potential side effects, follow dosage instructions diligently, and seek medical advice for any concerns or adverse reactions. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. Gynecology, Pediatrics, Dental care, and Dermatology. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

 For further information: 

  EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 BUY NOW

SHARE WITH